Related Experiment Video
Updated: Jul 13, 2026
06:57
Determining Basal Energy Expenditure and the Capacity of Thermogenic Adipocytes to Expend Energy in Obese Mice
Published on: November 11, 2021
Can pentobarbital replace amobarbital in the Wada test?
Jee Hyun Kim1, Eun Yeon Joo, Sun Jung Han
1Department of Neurology, College of Medicine, Ewha Womans University, Seoul, Korea.
Epilepsy & Behavior : E&B
|August 21, 2007
Summary
Pentobarbital (PTB) is a viable alternative to amobarbital (AMB) for Wada testing, showing similar efficacy in language and memory lateralization. PTB resulted in fewer instances of drowsiness and confusion post-injection compared to AMB.
Area of Science:
- Neurology
- Neuropsychology
- Clinical Neuroscience
Background:
- The Wada test is crucial for assessing hemispheric language and memory dominance.
- Amobarbital (AMB) is the standard agent, but alternatives are sought to improve patient tolerance.
- Pentobarbital (PTB) has been proposed as a potential substitute.
Purpose of the Study:
- To evaluate the efficacy and safety of pentobarbital (PTB) compared to amobarbital (AMB) in the Wada test.
- To determine if PTB provides equivalent language and memory lateralization assessment.
- To compare the incidence of adverse effects between PTB and AMB.
Main Methods:
- Retrospective analysis of 32 patients receiving PTB and 28 patients receiving AMB during Wada testing.
- Comparison of recovery times for motor activity and EEG delta slowing.
- Assessment of language lateralization and memory dominance.
- Documentation of adverse events, including drowsiness, confusion, and respiratory depression.
Main Results:
- No significant differences in recovery time or EEG delta slowing duration between PTB and AMB groups.
- Language lateralization was successfully established in both groups.
- PTB group showed a significantly lower incidence of post-injection drowsiness and confusion (P=0.043).
- Memory dominance patterns were comparable between groups, with a majority showing dominance in the non-epileptic hemisphere.
Conclusions:
- Pentobarbital (PTB) is an effective and potentially better-tolerated alternative to amobarbital (AMB) for Wada testing.
- PTB demonstrates equivalent utility for assessing language and memory lateralization.
- PTB is associated with a reduced risk of transient side effects like drowsiness and confusion.
More Related Videos
Related Concept Videos
01:20Sedatives and Hypnotics Drugs: Barbiturates
Sedatives and hypnotics encompass a drug class that acts on the central nervous system (CNS) to alleviate anxiety, promote relaxation and induce sleep.These drugs function by amplifying the actions of the neurotransmitter γ-aminobutyric acid (GABA), resulting in reduced neuronal activity. Barbiturates, a subset of sedatives and hypnotics first synthesized in the late 1800s, are categorized into ultra-short, short, intermediate, and long-acting groups based on their duration of effect. A key...
01:24Parenteral Anesthetics: Overview
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
01:14CNS Depressants: Barbiturates and Benzodiazepines
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
01:19Depolarizing Blockers: Pharmocokinetics
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
01:23Amines to Sulfonamides: The Hinsberg Test
The Hinsberg test is a method to identify primary, secondary and tertiary amines, named after its pioneer, Oscar Hinsberg. Here, amines are treated with benzenesulfonyl chloride, also known as the Hinsberg reagent, in the presence of an excess of aqueous base, followed by acidification. Based on the nature of the amines, different changes are observed.
Generally, a primary amine reacts with the Hinsberg reagent to produce an N-substituted benzenesulfonamide. The electron-withdrawing sulfonyl...
Generally, a primary amine reacts with the Hinsberg reagent to produce an N-substituted benzenesulfonamide. The electron-withdrawing sulfonyl...
01:19Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems
Phase I biotransformation reactions are integral to drug metabolism, predominantly involving oxidative, reductive, and hydrolytic transformations. Chief among these are oxidative reactions, which enhance the hydrophilicity of xenobiotics and introduce polar functional groups to facilitate their elimination from the body.
Oxidation reactions are fundamental in aromatic carbon-containing systems. An example is the hydroxylation of phenobarbital, a process that transforms it into...
Oxidation reactions are fundamental in aromatic carbon-containing systems. An example is the hydroxylation of phenobarbital, a process that transforms it into...